Simed Global

Simed Global is a UK-based healthcare technology company pioneering a revolutionary saliva-based diagnostic platform that delivers results in just 60 seconds. Designed to be fast, non-invasive, affordable, and adaptable, the platform is suitable for hospitals, clinics, and pharmacies worldwide. Our mission is to bring instant diagnostics to market through life changing in-vitro diagnostic (IVD) medical devices that enable rapid population wide screening for illnesses. By combining scientific innovation with practical clinical application, Simed Global is transforming how diseases are detected – making screening more accessible, efficient, and responsive to the evolving needs of modern healthcare systems globally.

Approach to Healthcare

Simed Global emphasises a collaborative, innovation-driven approach to healthcare diagnostics. Our model integrates technical expertise with commercial insights to accelerate the availability of rapid and accessible diagnostics. With a main focus on tackling AMR, Simed Global delivers world class precision diagnostics for a healthier future for all.

Impact of Product/Services on Healthcare

Simed Global’s diagnostic device, The Diagno, is capable of delivering results in 60 seconds and significantly improves clinical workflows. This is achieved by enabling medical professionals to make faster and more accurate diagnosis and treatment decisions. This innovation lowers unnecessary prescriptions by combating AMR head on and increasing early detection of infectious diseases and diagnosing correctly, ultimately reducing hospital burdens. Our global distribution partnerships allow access to consistent, quality diagnostics across diverse healthcare systems.

Innovation

Innovation is central to Simed Global’s mission. We have developed rapid IVD technologies that yield results far quicker than traditional lab tests. By leveraging advanced analytical methods and engaging in research collaboration, The Diagno continually refines new diagnostic capabilities. This expands the ability of bridging the gap between early stage concept and real world clinical utility.

Future Direction

Simed Global is scaling globally through partnerships and technology collaborations, such as a recent scientific partnership with HiMedia Laboratories to accelerate rapid diagnostics adoption worldwide. Our future focus remains on broadening access globally to instant diagnostics and supporting healthcare systems with rapid, accurate screening tools that strengthen patient outcomes and readiness for global health challenges.